|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.12 USD | +1.51% |
|
-0.33% | -5.29% |
| 15/04 | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating | MT |
| 13/04 | Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 292.33 | +28.15% | 15 | ||||||
| 648.28 | +23.11% | 25 | ||||||
| 591.51 | +26.06% | 30 | ||||||
| 256.05 | +31.47% | 22 | ||||||
| 96.66 | +50.48% | 32 | ||||||
| 54.02 | +38.84% | 20 | ||||||
| 96.33 | +18.94% | 27 | ||||||
| 160.69 | +31.85% | 16 | ||||||
| 90.74 | +21.53% | 19 | ||||||
| 385.5 | +17.61% | 22 | ||||||
| 27.98 | +10.36% | 20 | ||||||
| 244.13 | +55.75% | 19 | ||||||
| 136.11 | +1.2% | 18 | ||||||
| 1,750 | +10.51% | 13 | ||||||
| 115.13 | +22.53% | 15 | ||||||
| 46.79 | +14.95% | 14 | ||||||
| 10.26 | +0.95% | 3 | ||||||
| 30.99 | +4.11% | 7 | ||||||
| 155 | +33.77% | 10 | ||||||
| Average | 273.08 | +23.27% | 18 | ||||||
| Weighted average by Cap. | 359.36 | +28.23% | 24 |
- Stock Market
- Equities
- RMD Stock
- Sector ResMed, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition